Samsung Bioepis launches first biosimilar in Japan
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-05-20 12:08 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Asia, Economy & Finance, Financial Markets, World News, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
Samsung Bioepis said Wednesday it has launched autoimmune disease treatment SB17 in partnership with Nipro Corporation, marking the company’s first product launch in Japan and its full-scale entry into the market.
--------------------------------------------------------------------